Zenas BioPharma, Inc.
NASDAQ:ZBIO · NASDAQ Global Select
+$0.64 today
Vol 2.13M · Avg 0.71M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+108.87%
Period High
$43.17
Period Low
$9.14
Latest
$19.78
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Relay Therapeutics, Inc.
NASDAQ:RLAY
$2.82B
Trevi Therapeutics, Inc.
NASDAQ:TRVI
$2.37B
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$1.71B
Syndax Pharmaceuticals, Inc.
NASDAQ:SNDX
$1.70B
Novavax, Inc.
NASDAQ:NVAX
$1.52B
Inhibrx Biosciences, Inc.
NASDAQ:INBX
$1.35B
Amylyx Pharmaceuticals, Inc.
NASDAQ:AMLX
$1.28B
Wave Life Sciences Ltd.
NASDAQ:WVE
$1.17B
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
$886.63M
Upstream Bio, Inc.
NASDAQ:UPB
$344.48M
What is the latest ZBIO filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does ZBIO have?
Intrinsic Alpha currently shows 20 recent filings for ZBIO.
Explore More
Continue the stock analysis
Jump to another research area for this company.